Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of β-nicotinamide Mononucleotide Intervention on Healthy Young Subjects With Acute Binge Drink: a Double-blinded, Randomized, Crossover Trial

NCT05882214 is registered in ClinicalTrials.gov with Zhejiang Chinese Medical University as lead sponsor.

NCT NCT05882214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05882214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of β-nicotinamide Mononucleotide Intervention on Healthy Young Subjects With Acute Binge Drink: a Double-blinded, Randomized, Crossover Trial
Lead sponsor
Zhejiang Chinese Medical University
Phase
Phase 1/2
Overall status
Completed
Start date
May 1, 2024
Completion date
April 6, 2025
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

binge drinking, hepatic steatosis, liver injury, nutritional supplementation